To investigate the expression of FTO and STAT3 in BC-DoxR cells, two commercially available BC cell lines including MCF-7 and MDA-MB-231 were used to develop doxorubicin-resistant population MCF-7-DoxR and MDA-MB-231-DoxR. Here, FTO is linked to breast cancer.